Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8636 |
High Similarity |
NPD3705 |
Approved |
0.8421 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8421 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8421 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8312 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8224 |
Intermediate Similarity |
NPD37 |
Approved |
0.8014 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7975 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.795 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7875 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.782 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7785 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7758 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7746 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7724 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7724 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7589 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7589 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7569 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7362 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7357 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7355 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7278 |
Intermediate Similarity |
NPD1653 |
Approved |
0.726 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7237 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.723 |
Intermediate Similarity |
NPD5109 |
Approved |
0.723 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7203 |
Intermediate Similarity |
NPD1091 |
Approved |
0.72 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7192 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7179 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7134 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7133 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7133 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7117 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7111 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7099 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7099 |
Intermediate Similarity |
NPD3383 |
Approved |
0.7099 |
Intermediate Similarity |
NPD3382 |
Approved |
0.7099 |
Intermediate Similarity |
NPD3384 |
Approved |
0.7097 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7069 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7051 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7042 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7041 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7013 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7012 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7012 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD5006 |
Approved |
0.6995 |
Remote Similarity |
NPD5005 |
Approved |
0.6993 |
Remote Similarity |
NPD5691 |
Approved |
0.6989 |
Remote Similarity |
NPD6842 |
Approved |
0.6989 |
Remote Similarity |
NPD6841 |
Approved |
0.6989 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6986 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6986 |
Remote Similarity |
NPD5327 |
Phase 3 |
0.6972 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.697 |
Remote Similarity |
NPD3882 |
Suspended |
0.697 |
Remote Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6968 |
Remote Similarity |
NPD5762 |
Approved |
0.6968 |
Remote Similarity |
NPD5763 |
Approved |
0.6964 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6964 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6962 |
Remote Similarity |
NPD5058 |
Phase 3 |
0.6962 |
Remote Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD7680 |
Approved |
0.6951 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.695 |
Remote Similarity |
NPD709 |
Approved |
0.6948 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD5126 |
Approved |
0.6944 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6943 |
Remote Similarity |
NPD7466 |
Approved |
0.6937 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6933 |
Remote Similarity |
NPD5090 |
Approved |
0.6933 |
Remote Similarity |
NPD5089 |
Approved |
0.6923 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6908 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6897 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6886 |
Remote Similarity |
NPD919 |
Approved |
0.6879 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6879 |
Remote Similarity |
NPD4237 |
Approved |
0.6879 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD3445 |
Approved |
0.6875 |
Remote Similarity |
NPD3444 |
Approved |
0.6875 |
Remote Similarity |
NPD3443 |
Approved |
0.6871 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6868 |
Remote Similarity |
NPD4420 |
Approved |
0.6863 |
Remote Similarity |
NPD5735 |
Approved |
0.6863 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6852 |
Remote Similarity |
NPD4210 |
Discontinued |
0.6849 |
Remote Similarity |
NPD1611 |
Approved |
0.6848 |
Remote Similarity |
NPD2978 |
Approved |
0.6848 |
Remote Similarity |
NPD2801 |
Approved |
0.6848 |
Remote Similarity |
NPD2977 |
Approved |
0.6848 |
Remote Similarity |
NPD4585 |
Approved |
0.6848 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6839 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6839 |
Remote Similarity |
NPD3748 |
Approved |
0.6835 |
Remote Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6826 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD1372 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6805 |
Remote Similarity |
NPD1247 |
Approved |
0.68 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6797 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6795 |
Remote Similarity |
NPD2796 |
Approved |
0.6792 |
Remote Similarity |
NPD2677 |
Approved |
0.6786 |
Remote Similarity |
NPD228 |
Approved |
0.6784 |
Remote Similarity |
NPD4481 |
Phase 3 |
0.6784 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6784 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6784 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6778 |
Remote Similarity |
NPD7296 |
Approved |
0.6772 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.677 |
Remote Similarity |
NPD2532 |
Approved |
0.677 |
Remote Similarity |
NPD2534 |
Approved |
0.677 |
Remote Similarity |
NPD2533 |
Approved |
0.6768 |
Remote Similarity |
NPD4678 |
Approved |
0.6768 |
Remote Similarity |
NPD4675 |
Approved |
0.6765 |
Remote Similarity |
NPD6071 |
Discontinued |
0.6763 |
Remote Similarity |
NPD8156 |
Discontinued |
0.6759 |
Remote Similarity |
NPD1651 |
Approved |
0.6755 |
Remote Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.6752 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6747 |
Remote Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.6747 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6747 |
Remote Similarity |
NPD7819 |
Suspended |
0.6735 |
Remote Similarity |
NPD1281 |
Approved |
0.673 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6728 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6725 |
Remote Similarity |
NPD5242 |
Approved |
0.6713 |
Remote Similarity |
NPD6387 |
Discontinued |
0.6713 |
Remote Similarity |
NPD7157 |
Approved |
0.6712 |
Remote Similarity |
NPD4626 |
Approved |
0.6711 |
Remote Similarity |
NPD6696 |
Suspended |
0.6711 |
Remote Similarity |
NPD2922 |
Phase 1 |
0.6711 |
Remote Similarity |
NPD8651 |
Approved |
0.6708 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6707 |
Remote Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD5353 |
Approved |
0.6705 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6705 |
Remote Similarity |
NPD8251 |
Approved |
0.6705 |
Remote Similarity |
NPD8099 |
Discontinued |
0.6705 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6705 |
Remote Similarity |
NPD8252 |
Approved |
0.6691 |
Remote Similarity |
NPD2684 |
Approved |
0.6689 |
Remote Similarity |
NPD1840 |
Phase 2 |
0.6688 |
Remote Similarity |
NPD6099 |
Approved |
0.6688 |
Remote Similarity |
NPD6100 |
Approved |
0.6688 |
Remote Similarity |
NPD2161 |
Phase 2 |
0.6688 |
Remote Similarity |
NPD4140 |
Approved |
0.6688 |
Remote Similarity |
NPD3454 |
Phase 3 |
0.6687 |
Remote Similarity |
NPD5976 |
Discontinued |
0.6667 |
Remote Similarity |
NPD6895 |
Approved |
0.6667 |
Remote Similarity |
NPD3051 |
Approved |
0.6667 |
Remote Similarity |
NPD1139 |
Approved |
0.6667 |
Remote Similarity |
NPD6896 |
Approved |
0.6667 |
Remote Similarity |
NPD1137 |
Approved |
0.6667 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6647 |
Remote Similarity |
NPD3489 |
Phase 3 |
0.6645 |
Remote Similarity |
NPD1933 |
Approved |
0.6645 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6645 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6644
|
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |